Additionally, after using the propensity score matching (PSM) method to eliminate the confounding effect of tumor stage on survival outcomes, Kaplan-Meier survival curves were plotted in EGFR-mutant NSCLC patients. This evidence concerns the gene EGFR and non-small cell lung carcinoma.